{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:02:55Z","timestamp":1793145775136,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Maternal HIV infection and antiretroviral drugs (ARVs) are associated with increased risks of adverse perinatal outcomes. The vast majority of pregnant women living with HIV (WLHIV) reside in sub-Saharan Africa. We aimed to determine the burden of adverse perinatal outcomes attributable to HIV and ARVs in sub-Saharan Africa between\u00a01990\u00a0and\u00a02020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conduct a systematic review of studies on the association of pregnant WLHIV with adverse perinatal outcomes in sub-Saharan Africa. We perform random-effects meta-analyses to determine the risk difference (attributable risk, AR) of perinatal outcomes among WLHIV receiving no ARVs, monotherapy, or combination antiretroviral therapy (cART) initiated antenatally or preconception, compared to HIV-negative women. We estimate numbers of perinatal outcomes attributable to HIV and ARVs by combining the AR values with numbers of WLHIV receiving different ARV regimens in each country in sub-Saharan Africa annually between 1990 and 2020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We find that WLHIV receiving no ARVs or cART initiated antenatally or preconception, but not monotherapy, have an increased risk of preterm birth (PTB), low birthweight (LBW) and small for gestational age (SGA), compared to HIV-negative women. Between 1990\u00a0and\u00a02020, 1,921,563 PTBs, 2,119,320 LBWs, and 2,049,434 SGAs are estimated to be attributable to HIV and ARVs in sub-Saharan Africa, mainly among WLHIV receiving no ARVs, while monotherapy and preconception and antenatal cART averted many adverse outcomes. In 2020, 64,585 PTBs, 58,608 LBWs, and 61,112 SGAs were estimated to be attributable to HIV and ARVs, the majority among WLHIV receiving preconception cART.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>As the proportion of WLHIV receiving preconception cART increases, the burden of adverse perinatal outcomes among WLHIV in sub-Saharan Africa is likely to remain high.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration number<\/jats:title>\n                <jats:p>CRD42021248987<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s43856-023-00331-8","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T13:01:44Z","timestamp":1690030904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Adverse perinatal outcomes attributable to HIV in sub-Saharan Africa from 1990 to 2020: Systematic review and meta-analyses"],"prefix":"10.1038","volume":"3","author":[{"given":"Claudia","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Portwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kumarendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Kirtley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-7457","authenticated-orcid":false,"given":"Joris","family":"Hemelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"key":"331_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD.","year":"2020","unstructured":"GBD. 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 396, 1204\u20131222 (2020).","journal-title":"Lancet."},{"key":"331_CR2","unstructured":"United Nations. Transforming our world: The 2030 agenda for sustainable development. (2015)."},{"key":"331_CR3","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0140-6736(21)01207-1","volume":"398","author":"GBD.","year":"2021","unstructured":"GBD. Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet 398, 870\u2013905 (2021).","journal-title":"Lancet"},{"key":"331_CR4","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","volume":"388","author":"L Liu","year":"2016","unstructured":"Liu, L. et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388, 3027\u20133035 (2016).","journal-title":"Lancet"},{"key":"331_CR5","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/S2214-109X(18)30451-0","volume":"7","author":"S Chawanpaiboon","year":"2019","unstructured":"Chawanpaiboon, S. et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob. Health 7, e37\u2013e46 (2019).","journal-title":"Lancet Glob. Health"},{"key":"331_CR6","doi-asserted-by":"publisher","first-page":"j3677","DOI":"10.1136\/bmj.j3677","volume":"358","author":"AC Lee","year":"2017","unstructured":"Lee, A. C. et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets. BMJ. 358, j3677 (2017).","journal-title":"BMJ."},{"key":"331_CR7","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S2214-109X(13)70006-8","volume":"1","author":"AC Lee","year":"2013","unstructured":"Lee, A. C. et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob. Health 1, e26\u2013e36 (2013).","journal-title":"Lancet Glob. Health"},{"key":"331_CR8","unstructured":"UNAIDS. Global AIDS Update. (2021)."},{"key":"331_CR9","unstructured":"World Health Organization. Consolidated Guidelines On HIV Prevention, Testing, Treatment, Service Delivery And Monitoring: Recommendations For A Public Health Approach. (2021)."},{"key":"331_CR10","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","volume":"331","author":"EM Connor","year":"1994","unstructured":"Connor, E. M. et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. New Engl. J. Med. 331, 1173\u20131180 (1994).","journal-title":"New Engl. J. Med."},{"key":"331_CR11","unstructured":"World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for a public health approach. (2010)."},{"key":"331_CR12","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. (2013)."},{"key":"331_CR13","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Second edition. (2016)."},{"key":"331_CR14","unstructured":"Start Free, Stay Free, AIDS Free. (2019)."},{"key":"331_CR15","unstructured":"UNAIDS. UNAIDS Data. (2020)."},{"key":"331_CR16","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","volume":"3","author":"CO Wedi","year":"2016","unstructured":"Wedi, C. O. et al. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV 3, e33\u2013e48 (2016).","journal-title":"Lancet HIV"},{"key":"331_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/infdis\/jiv390","volume":"213","author":"LM Mofenson","year":"2016","unstructured":"Mofenson, L. M. Antiretroviral Therapy and Adverse Pregnancy Outcome: The Elephant in the Room? J. Infec. Dis. 213, 1051\u20131054 (2016).","journal-title":"J. Infec. Dis."},{"key":"331_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","volume":"21","author":"AP Kourtis","year":"2007","unstructured":"Kourtis, A. P., Schmid, C. H., Jamieson, D. J. & Lau, J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: A meta-analysis. AIDS 21, 607\u2013615 (2007).","journal-title":"AIDS"},{"key":"331_CR19","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1097\/QAD.0000000000002593","volume":"34","author":"COO Tshivuila-Matala","year":"2020","unstructured":"Tshivuila-Matala, C. O. O. et al. Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis. AIDS. 34, 1643\u20131656 (2020).","journal-title":"AIDS."},{"key":"331_CR20","doi-asserted-by":"publisher","first-page":"e027344","DOI":"10.1136\/bmjopen-2018-027344","volume":"9","author":"Y Ejigu","year":"2019","unstructured":"Ejigu, Y., Magnus, J. H., Sundby, J. & Magnus, M. C. Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study. BMJ Open 9, e027344 (2019).","journal-title":"BMJ Open"},{"key":"331_CR21","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/j.1471-0528.2010.02689.x","volume":"117","author":"SJ Townsend CL","year":"2010","unstructured":"Townsend CL, S. J. et al. Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. BJOG 117, 1399\u20131410 (2010).","journal-title":"BJOG"},{"key":"331_CR22","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1086\/503049","volume":"193","author":"RE Tuomala","year":"2006","unstructured":"Tuomala, R. E. & Yawetz, S. Protease inhibitor use during pregnancy: is there an obstetrical risk? J. Infect. Dis. 193, 1191\u20131194 (2006).","journal-title":"J. Infect. Dis."},{"key":"331_CR23","first-page":"13326","volume":"6","author":"H Sexton","year":"2022","unstructured":"Sexton, H. et al. Adverse perinatal outcomes associated with timing of initiation of antiretroviral therapy: Systematic review and meta-analysis. HIV Med. 6, 13326 (2022).","journal-title":"HIV Med."},{"key":"331_CR24","doi-asserted-by":"crossref","unstructured":"Higgins, J., eds. Cochrane handbook for systematic reviews of interventions. (2008).","DOI":"10.1002\/9780470712184"},{"key":"331_CR25","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 339, b2535 (2009).","journal-title":"BMJ."},{"key":"331_CR26","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","volume":"379","author":"H Blencowe","year":"2012","unstructured":"Blencowe, H. et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379, 2162\u20132172 (2012).","journal-title":"Lancet"},{"key":"331_CR27","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","volume":"384","author":"J Villar","year":"2014","unstructured":"Villar, J. et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 384, 857\u2013868 (2014).","journal-title":"Lancet"},{"key":"331_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0140-6736(05)71048-5","volume":"365","author":"JE Lawn","year":"2005","unstructured":"Lawn, J. E., Cousens, S. & Zupan, J. 4 million neonatal deaths: when? Where? Why? Lancet. 365, 891\u2013900 (2005).","journal-title":"Lancet."},{"key":"331_CR29","first-page":"198","volume":"113","author":"GA Wells","year":"2014","unstructured":"Wells, G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hosp. Res. Inst. 113, 198\u2013199 (2014).","journal-title":"Ottawa Hosp. Res. Inst."},{"key":"331_CR30","unstructured":"Adjorlolo G. et al. in Proceeding of the 5th International Conference on AIDS (Quebec, Canada, 1991)."},{"key":"331_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/00002030-200303070-00014","volume":"17","author":"JG Ayisi","year":"2003","unstructured":"Ayisi, J. G. et al. The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS. 17, 585\u2013594 (2003).","journal-title":"AIDS."},{"key":"331_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ppe.12688","volume":"34","author":"AM Bengtson","year":"2020","unstructured":"Bengtson, A. M. et al. Does HIV infection modify the relationship between pre-pregnancy body mass index and adverse birth outcomes? Paediatr. Perinat. Epidemiol. 34, 713\u2013723 (2020).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"331_CR33","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/00002030-199010000-00009","volume":"4","author":"MR Braddick","year":"1990","unstructured":"Braddick, M. R. et al. Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS. 4, 1001\u20131005 (1990).","journal-title":"AIDS."},{"key":"331_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00006454-199402000-00003","volume":"13","author":"M Bulterys","year":"1994","unstructured":"Bulterys, M. et al. Maternal human immunodeficiency virus 1 infection and intrauterine growth: a prospective cohort study in Butare, Rwanda. Pediatr. Infect Dis. J. 13, 94\u2013100 (1994).","journal-title":"Pediatr. Infect Dis. J."},{"key":"331_CR35","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/infdis\/jis553","volume":"206","author":"JY Chen","year":"2012","unstructured":"Chen, J. Y. et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J. Infect. Dis. 206, 1695\u20131705 (2012).","journal-title":"J. Infect. Dis."},{"key":"331_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijgo.2016.03.021","volume":"134","author":"CJ Chibwesha","year":"2016","unstructured":"Chibwesha, C. J. et al. Predictors and outcomes of low birth weight in Lusaka, Zambia. Int. J. Gynaecol. Obstet. 134, 309\u2013314 (2016).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"331_CR37","first-page":"1125","volume":"108","author":"JL Coley","year":"2001","unstructured":"Coley, J. L. et al. The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania. BJOG. 108, 1125\u20131133 (2001).","journal-title":"BJOG."},{"key":"331_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/QAI.0000000000001875","volume":"80","author":"S Dadabhai","year":"2019","unstructured":"Dadabhai, S. et al. Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study). J. Acquir. Immune Defic. Syndr. 80, 7\u201314 (2019).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"331_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1258\/ijsa.2008.008446","volume":"20","author":"VC Ezeaka","year":"2009","unstructured":"Ezeaka, V. C., Iroha, E. O., Akinsulie, A. O., Temiye, E. O. & Adetifa, I. M. Anthropometric indices of infants born to HIV-1-infected mothers: a prospective cohort study in Lagos, Nigeria. Int. J. STD AIDS 20, 545\u2013548 (2009).","journal-title":"Int. J. STD AIDS"},{"key":"331_CR40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1079\/BJN20041275","volume":"92","author":"H Friis","year":"2004","unstructured":"Friis, H. et al. Maternal body composition, HIV infection and other predictors of gestation length and birth size in Zimbabwe. Br. J. Nutr. 92, 833\u2013840 (2004).","journal-title":"Br. J. Nutr."},{"key":"331_CR41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1471-0528.2008.01672.x","volume":"115","author":"NA Habib","year":"2008","unstructured":"Habib, N. A. et al. Maternal HIV status and pregnancy outcomes in northeastern Tanzania: a registry-based study. BJOG 115, 616\u2013624 (2008).","journal-title":"BJOG"},{"key":"331_CR42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00002030-198910000-00004","volume":"3","author":"M Lallemant","year":"1989","unstructured":"Lallemant, M. et al. Mother-child transmission of HIV-1 and infant survival in Brazzaville, Congo. AIDS. 3, 643\u2013646 (1989).","journal-title":"AIDS."},{"key":"331_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00002030-199103000-00008","volume":"5","author":"P Lepage","year":"1991","unstructured":"Lepage, P. et al. Perinatal transmission of HIV-1: lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda. AIDS. 5, 295\u2013300 (1991).","journal-title":"AIDS."},{"key":"331_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00002030-199806000-00014","volume":"12","author":"V Leroy","year":"1998","unstructured":"Leroy, V. et al. Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group. AIDS. 12, 643\u2013650 (1998).","journal-title":"AIDS."},{"key":"331_CR45","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/ije\/dyx136","volume":"46","author":"TR Malaba","year":"2017","unstructured":"Malaba, T. R. et al. Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women. Int. J. Epidemiol. 46, 1678\u20131689 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"331_CR46","first-page":"32","volume":"11","author":"NC Mmiro FA","year":"1993","unstructured":"Mmiro FA, N. C., Guy, L., Galdforb, J., Horm, D. & Olness, K. The effect of human immunodeficiency virus infection on the outcome of pregnancy in Ugandan women. J. Obstet. Gynaecol. East Cent. Afr. 11, 32\u201337 (1993).","journal-title":"J. Obstet. Gynaecol. East Cent. Afr."},{"key":"331_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-016-0821-3","volume":"16","author":"T Moodley","year":"2016","unstructured":"Moodley, T., Moodley, D., Sebitloane, M., Maharaj, N. & Sartorius, B. Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa. BMC Preg. Childbirth 16, 35 (2016).","journal-title":"BMC Preg. Childbirth"},{"key":"331_CR48","first-page":"480","volume":"86","author":"JW Musana","year":"2009","unstructured":"Musana, J. W., Ojwang, S. B., Khisa, W. & Kiarie, J. N. Pregnancy outcomes in mothers with advanced human immunodeficiency virus disease. East Afr. Med. J. 86, 480\u2013485 (2009).","journal-title":"East Afr. Med. J."},{"key":"331_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/01443610020022078","volume":"21","author":"F Mwanyumba","year":"2001","unstructured":"Mwanyumba, F. et al. Correlation between maternal and infant HIV infection and low birth weight: a study in Mombasa, Kenya. J Obstet Gynaecol 21, 27\u201331 (2001).","journal-title":"J Obstet Gynaecol"},{"key":"331_CR50","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/humrep\/des090","volume":"27","author":"J Ndirangu","year":"2012","unstructured":"Ndirangu, J., Newell, M. L., Bland, R. M. & Thorne, C. Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod 27, 1846\u20131856 (2012).","journal-title":"Hum Reprod"},{"key":"331_CR51","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00404-009-1186-x","volume":"281","author":"BN Olagbuji","year":"2010","unstructured":"Olagbuji, B. N., Ezeanochie, M. C., Ande, A. B. & Oboro, V. O. Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria. Arch. Gynecol. Obstet. 281, 991\u2013994 (2010).","journal-title":"Arch. Gynecol. Obstet."},{"key":"331_CR52","doi-asserted-by":"publisher","first-page":"ofx187","DOI":"10.1093\/ofid\/ofx187","volume":"4","author":"V Ramokolo","year":"2017","unstructured":"Ramokolo, V. et al. In Utero ART Exposure and Birth and Early Growth Outcomes Among HIV-Exposed Uninfected Infants Attending Immunization Services: Results From National PMTCT Surveillance, South Africa. Open Forum Infect Dis. 4, ofx187 (2017).","journal-title":"Open Forum Infect Dis."},{"key":"331_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-017-1263-2","volume":"17","author":"EM Rempis","year":"2017","unstructured":"Rempis, E. M. et al. Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda. BMC Preg. Childbirth 17, 82 (2017).","journal-title":"BMC Preg. Childbirth"},{"key":"331_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/QAI.0b013e31802ea4b0","volume":"44","author":"NC Rollins","year":"2007","unstructured":"Rollins, N. C. et al. Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. J. Acquir Immune Defic. Syndr. 44, 321\u2013328 (2007).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"331_CR55","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJM198906223202501","volume":"320","author":"RW Ryder","year":"1989","unstructured":"Ryder, R. W. et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N. Engl. J. Med. 320, 1637\u20131642 (1989).","journal-title":"N. Engl. J. Med."},{"key":"331_CR56","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.4103\/njcp.njcp_328_16","volume":"20","author":"HM Sebitloane","year":"2017","unstructured":"Sebitloane, H. M. & Moodley, J. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa. Niger. J. Clin. Pract. 20, 1360\u20131367 (2017).","journal-title":"Niger. J. Clin. Pract."},{"key":"331_CR57","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S0002-9378(99)70509-0","volume":"181","author":"MY Sutton","year":"1999","unstructured":"Sutton, M. Y. et al. Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected congolese women: prevalence, risk factors, and association with low birth weight. Am. J. Obstet. Gynecol. 181, 656\u2013662 (1999).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"331_CR58","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/ije\/24.5.1022","volume":"24","author":"TE Taha","year":"1995","unstructured":"Taha, T. E. et al. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Int. J. Epidemiol. 24, 1022\u20131029 (1995).","journal-title":"Int. J. Epidemiol."},{"key":"331_CR59","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00006250-199404000-00002","volume":"83","author":"M Temmerman","year":"1994","unstructured":"Temmerman, M. et al. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet. Gynecol. 83, 495\u2013501 (1994).","journal-title":"Obstet. Gynecol."},{"key":"331_CR60","doi-asserted-by":"publisher","first-page":"e0226339","DOI":"10.1371\/journal.pone.0226339","volume":"14","author":"A Tiam","year":"2019","unstructured":"Tiam, A. et al. Comparison of 6-week PMTCT outcomes for HIV-exposed and HIV-unexposed infants in the era of lifelong ART: Results from an observational prospective cohort study. PLoS One 14, e0226339 (2019).","journal-title":"PLoS One"},{"key":"331_CR61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00126334-200311010-00005","volume":"34","author":"C Ticconi","year":"2003","unstructured":"Ticconi, C. et al. Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J. Acquir. Immune Defic. Syndr. 34, 289\u2013294 (2003).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"331_CR62","doi-asserted-by":"crossref","unstructured":"Zash, R. et al. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy. JAMA pediatrics 171, e172222 (2017).","DOI":"10.1001\/jamapediatrics.2017.2222"},{"key":"331_CR63","doi-asserted-by":"publisher","first-page":"e804","DOI":"10.1016\/S2214-109X(18)30218-3","volume":"6","author":"R Zash","year":"2018","unstructured":"Zash, R. et al. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study. Lancet Glob. Health 6, e804\u2013e810 (2018).","journal-title":"Lancet Glob. Health"},{"key":"331_CR64","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/S2352-3018(17)30046-2","volume":"4","author":"JS Stringer","year":"2017","unstructured":"Stringer, J. S., Stoner, M. C., Kasaro, M. P., Vwalika, B. & Cole, S. R. Preconception ART and preterm birth: real effect or selection bias? Lancet HIV 4, e150 (2017).","journal-title":"Lancet HIV"},{"key":"331_CR65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(13)60993-9","volume":"382","author":"J Katz","year":"2013","unstructured":"Katz, J. et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet 382, 417\u2013425 (2013).","journal-title":"Lancet"},{"key":"331_CR66","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1016\/S2352-3018(18)30059-6","volume":"5","author":"H Bailey","year":"2018","unstructured":"Bailey, H., Zash, R., Rasi, V. & Thorne, C. HIV treatment in pregnancy. Lancet HIV 5, e457\u2013e467 (2018).","journal-title":"Lancet HIV"},{"key":"331_CR67","first-page":"101368","volume":"46","author":"I Cowdell","year":"2022","unstructured":"Cowdell, I. et al. Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis. E Clin. Med. 46, 101368 (2022).","journal-title":"E Clin. Med."},{"key":"331_CR68","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJMoa1905230","volume":"381","author":"R Zash","year":"2019","unstructured":"Zash, R. et al. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. New Engl. J. Med. 381, 827\u2013840 (2019).","journal-title":"New Engl. J. Med."},{"key":"331_CR69","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(21)00314-7","volume":"397","author":"S Lockman","year":"2021","unstructured":"Lockman, S. et al. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010\/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 397, 1276\u20131292 (2021).","journal-title":"Lancet."},{"key":"331_CR70","first-page":"00249","volume":"2","author":"CE Dunk","year":"2021","unstructured":"Dunk, C. E. & Serghides, L. Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua. Lancet HIV 2, 00249\u201300246 (2021).","journal-title":"Lancet HIV"},{"key":"331_CR71","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12079","volume":"254","author":"M Paiardini","year":"2013","unstructured":"Paiardini, M. & M\u00fcller-Trutwin, M. HIV-associated chronic immune activation. Immunol. Rev. 254, 78\u2013101 (2013).","journal-title":"Immunol. Rev."},{"key":"331_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69966-0","volume":"10","author":"C Akoto","year":"2020","unstructured":"Akoto, C. et al. Innate Lymphoid Cells Are Reduced in Pregnant HIV Positive Women and Are Associated with Preterm Birth. Sci. Rep. 10, 13265 (2020).","journal-title":"Sci. Rep."},{"key":"331_CR73","doi-asserted-by":"publisher","first-page":"e13240","DOI":"10.1111\/aji.13240","volume":"83","author":"K Ravi","year":"2020","unstructured":"Ravi, K. et al. Changes in the V\u03b17.2+ CD161++ MAIT cell compartment in early pregnancy are associated with preterm birth in HIV-positive women. Am. J. Reprod. Immunol. 83, e13240 (2020).","journal-title":"Am. J. Reprod. Immunol."},{"key":"331_CR74","doi-asserted-by":"publisher","DOI":"10.11038\/s41598-10021-89551-10073.","volume":"11","author":"C Akoto","year":"2021","unstructured":"Akoto, C., Norris, S. A. & Hemelaar, J. Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in South African women. Sci. Rep. 11, 10079\u00a0(2021).","journal-title":"Sci. Rep."},{"key":"331_CR75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/infdis\/jiu393","volume":"211","author":"E Papp","year":"2015","unstructured":"Papp, E. et al. HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction. J. Infec. Dis. 211, 10\u201318 (2015).","journal-title":"J. Infec. Dis."},{"key":"331_CR76","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1016\/S2352-3018(21)00150-8","volume":"8","author":"JT Price","year":"2021","unstructured":"Price, J. T. et al. Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial. Lancet HIV 8, e605\u2013e613 (2021).","journal-title":"Lancet HIV"}],"updated-by":[{"DOI":"10.1038\/s43856-023-00415-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000}}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00331-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00331-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00331-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T08:04:26Z","timestamp":1702454666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00331-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00331-8","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s43856-023-00415-5","asserted-by":"object"}]},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,22]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s43856-023-00415-5","URL":"https:\/\/doi.org\/10.1038\/s43856-023-00415-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}